Lupin unveils generic version of Sun Pharma Westcort Cream to treat skin conditions

Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of the Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc., Lupin said.

New Delhi: Pharma major Lupin Limited (Lupin) recently announced the launch of Hydrocortisone Valerate Cream USP, 0,2%, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier.

Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of the Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc.

It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients.

Also Read: Lupin to sell Japanese arm Kyowa Pharma to Unison for Rs 3702 crore

Hydrocortisone Valerate Cream USP, 0.2%, (RLD: Westcort Cream) had an annual sales of approximately USD 11.5 million in the U.S. (IQVIA MAT September 2019).

Headquartered in Mumbai, Lupin develops and delivers a wide range of branded and generic formulations, biosimilar products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds a global position in the Anti-TB segment.

Also Read: Lupin gets USFDA nod for a generic equivalent of Zyflo CR Extended-Release Tablets to treat prophylaxis, asthma